Outcomes from RESONATE Trial in Relapsed CLL

Outcomes from RESONATE Trial in Relapsed CLL
Don Photo

Don
3 roky 81 Zobrazení
Kategorie:
Popis:
Paul M.Barr MD Associate Professor of Medicine at Wilmot Cancer Institute explains the results found of the RESONATE Trial that was evaluating ibrutinib versus ofatumumab in relapsed chronic lymphocytic leukemia (CLL).